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Receptor-Specific Signaling for Both the
Alternative and the Canonical NF-B Activation
Pathways by NF-B-Inducing Kinase
lating protein kinase, IKK2, which occurs within a macro-
molecular complex, the “IKK signalosome,” in associa-
tion with a structurally homologous kinase, IKK1, and
an adaptor protein, NEMO. IKK2-mediated phosphory-
lation of IB leads to its proteasomal degradation and,
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hence, activation of its associated NF-B dimers. Re-Israel
cent work has yielded some knowledge of an “alterna-
tive” pathway through which NF-B dimers containing
p100 are activated. This activation occurs independentlySummary
of IKK2 or NEMO but is dependent on IKK1. Phosphory-
lation of p100 upon activation of this pathway leads toThe NF-B-inducing kinase (NIK) induces proteolytic
limited proteolytic processing in which only the IB-processing of NF-B2/p100 and, hence, the generation
homologous region within p100 is degraded, allowingof NF-B dimers such as p52:RelB but was suggested
the resulting p52 fragment to translocate to the nucleusnot to signal for the processing of IB. Here, we show
in association with some other NF-B proteins (mainlythat although the induction of IB degradation in lym-
RelB) (Xiao et al., 2001; Senftleben et al., 2001; Solanphocytes by TNF is independent of NIK, its induction
et al., 2002; Coope et al., 2002; Claudio et al., 2002;by CD70, CD40 ligand, and BLyS/BAFF, which all also
Kayagaki et al., 2002; Dejardin et al., 2002; Yilmaz et al.,induce NF-B2/p100 processing, does depend on NIK
2003; Hatada et al., 2003).function. Both CD70 and TNF induce recruitment of
Members of the tumor necrosis factor/nerve growththe IKK kinase complex to their receptors. In the case
factor (TNF/NGF) receptor family control multiple im-of CD70, but not TNF, this process is associated with
mune-defense activities as well as certain develop-NIK recruitment and is followed by prolonged receptor
mental processes through NF-B activation (Wallach etassociation of just IKK1 and NIK. Recruitment of the
al., 1999; Locksley et al., 2001). Most of these receptorsIKK complex to CD27, but not that of NIK, depends
are capable of activating the canonical NF-B pathway.on NIK kinase function. Our findings indicate that NIK
In addition, the lymphotoxin- receptor (LTR), whoseparticipates in a unique set of proximal signaling
expression is restricted to stromal cells, and severalevents initiated by specific inducers, which activate
receptors that occur in lymphocytes, including CD40,both canonical and noncanonical NF-B dimers.
the BLyS/BAFF receptor, and (as shown here) CD27,
also activate the alternative pathway.Introduction
Signaling for NF-B activation by several receptors
of the family is initiated by their binding to adaptor pro-Inducible activation of the dimeric NF-B/Rel transcrip-
teins of the TRAF family. In cells treated with TNF, thetion factors contributes to the regulation of a wide array
TRAFs have been shown to facilitate, collaborativelyof genes. In mammals, this family of transcription factors
with the adaptor protein RIP, recruitment of the signalo-is comprised of five members: p65 (RelA), RelB, c-Rel,
some components to the p55 TNF receptor (Zhang etNF-B1 (which occurs both as a precursor, p105, and
al., 2000; Devin et al., 2000, 2001). While searching forin a processed form, p50), and NF-B2 (which occurs
additional proteins that participate in NF-B activationboth as a precursor, p100, and as its processed product,
by the TNF/NGF receptor family, we identified a TRAFp52). Prior to activation, homo- and heterodimers of
binding serine/threonine protein kinase related to the
these proteins are retained in the cytoplasm by their
MAP3Ks, which can strongly activate NF-B and was
association with inhibitory proteins of the IB family.
therefore dubbed “NF-B-inducing kinase” (NIK) (Mali-
The precursor forms of NF-B1 and NF-B2 (p105 and nin et al., 1997).
p100, respectively) contain C-terminal IB-homologous Initial studies of the function of NIK in which the conse-
inhibitory regions. Dimers containing these NF-B pro- quences of overexpression of this kinase and of its mu-
teins are retained in the cytoplasm by virtue of the func- tants in cells were assessed suggested that NIK medi-
tion of the IB-homologous regions. Moreover, p105 ates activation of the canonical NF-B pathway and that
and p100 can also associate with dimers of other NF- it does so in response to multiple inducers with many
B proteins and impose cytoplasmic retention on them. different physiological functions. However, later studies
Activation occurs by a variety of different agents, mainly of mice of the aly strain, which express a nonfunctional
through induced degradation of the IB proteins or of NIK mutant, as well as of NIK-knockout mice, challenged
IB-homologous regions in p105 and p100, and conse- the notion that NIK has a functional role in the activities
quent translocation of the NF-B dimers to the nucleus of most of these inducers. They suggested, rather, that
(Ghosh and Karin, 2002). NIK participates selectively in the activation of NF-B
Most of our current knowledge of these processes by a restricted set of ligands that specifically affect the
concerns the mechanisms of activation of a ubiquitous development and function of lymphocytes (Shinkura et al.,
NF-B dimer, p65:p50. The critical event in initiating this 1999; Yin et al., 2001). Moreover, based on characterization
“canonical” pathway is activation of an IB-phosphory- of cells derived from these mutant mice, it was suggested
that NIK does not participate at all in the canonical NF-
B pathway but, rather, serves exclusively to activate*Correspondence: d.wallach@weizmann.ac.il
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the alternative one (see Pomerantz and Baltimore [2002] cess was blocked by the proteasomal inhibitor MG132
(Figures 1G and 1H). In the presence of MG132, CD70for review). Since lymphocytes of NIK mutant mice ex-
hibit a highly aberrant pattern of differentiation (Miya- induced accumulation of polyubiquitinated p100 mole-
cules in the Ramos cells (Figure 1I), testifying to ubiquiti-waki et al., 1994; Shinkura et al., 1999; Matsumoto et al.,
1999; Yamada et al., 2000; Karrer et al., 2000; Fagarasan nation followed by proteasomal processing of p100 in
the generation of p52.et al., 2000), we questioned the validity of assessing the
signaling role of NIK in them by comparing NIK activity
in lymphocytes derived from NIK mutant mice to that in Depletion of NIK in Ramos Lymphoblastoid Cells
lymphocytes of wild-type mice. or Its Replacement with Nonfunctional NIK
In this study, we reevaluated the function of NIK in Mutants Blocks CD27-Induced Activation
lymphocytes by assessing the effect of its depletion or of Both the Canonical and the Alternative
inhibition in vitro in cultured cells of lymphoblastoid NF-B Pathways
lines. We confirmed that NIK is not required in lympho- To examine the participation of NIK in activation of the
cytes for activation of the canonical pathway by TNF. various NF-B forms by CD27, we attempted to arrest
However, we found that NIK plays a crucial role in these the synthesis of NIK in Ramos cells by infecting them
cells in activation of the alternative as well as of the with a lentiviral vector expressing hairpin short interfer-
canonical pathway by CD40 ligand (CD40L) and BLyS/ ing RNA (siRNA) of NIK. Western analysis confirmed that
BAFF. Furthermore, we showed that CD27, a receptor both in transient transfection and in stable expression,
of the TNF/NGF family that is expressed mainly in T lym- the siRNA vector effectively arrested the synthesis of
phocytes and memory B lymphocytes, also requires NIK NIK (Figure 2A, top and middle). Treatment of the NIK-
for the induction of both the canonical and the alterna- deficient (NIK) cells with CD70 failed to induce translo-
tive pathways. Analysis of the proximal signaling events cation of p52 or of RelB to their nuclei (Figure 1D, right).
initiated by CD27 revealed that NIK and, in a way that Surprisingly, it also resulted in inability of CD70 to induce
depends on NIK’s kinase function, the IKK signalosome IB degradation or nuclear p65 translocation, both mani-
are recruited to this receptor. Triggering of the p55 TNF festations of the canonical pathway (Figure 1E, right).
receptor induces prolonged receptor recruitment of the Control tests confirmed that the NIK Ramos cells
whole signalosome, whereas triggering of CD27 induces express CD27 at levels comparable to those in normal
transient signalosome recruitment followed by selective Ramos cells and manifest a normal extent of protein
maintenance of just IKK1 together with NIK in the re- kinase C (PKC) activation upon CD27 triggering (Erlich-
ceptor complex, a process that might constitute the man and Howard, 1999) (Figure 2B and its inset), exclud-
initiating events in the NIK-dependent activation of the ing a general aberration of CD27 function as a cause of
canonical and, subsequently, of the alternative NF-B the inability of the NIK cells to manifest activation of
pathways by CD27. NF-B by this receptor.
To verify that this inability indeed results from the
absence of NIK, we restored NIK expression in the NIKResults
cells (Figure 2A, bottom). Cells reconstituted with wild-
type NIK regained the ability to respond to CD70 withCD27 Induces Processing of Both IB
both an increase in nuclear p52 and a transient decreaseand NF-B2/p100 in Lymphocytes
in IB (Figure 2C). On the other hand, expression ofWe recently found that SIVA, a protein previously shown
an enzymatically inactive NIK mutant (KD-NIK) in theto associate with the TNF/NGF receptor family member
NIK cells failed to restore their response to either ofCD27, binds to NIK and controls its function (Ramakrish-
the CD70 effects. Expression of NIK with a missensenan et al., submitted). This finding led us to suspect
mutation corresponding to that of aly mice (aly-NIK)that NIK plays a role in CD27 signaling. We therefore
prompted spontaneous generation of nuclear p52 butexamined the effect of CD27 on the alternative NF-B
did not restore the ability of the NIK cells to respondactivation pathway in which NIK function has been impli-
to CD70 (Figure 2D).cated.
Treatment of human peripheral blood mononuclear
cells (PBMC) with CD70 induced rapid decrease of IB, Depletion of NIK in Lymphoblastoid Cells Blocks
Activation of Both the Canonical and the Alternativeindicating that CD27 can trigger activation of the canoni-
cal NF-B pathway (Figures 1A and 1B). In resting NF-B Pathways by CD40L and BLyS/BAFF,
but Not Activation of the Canonical PathwayPBMC, CD70 also induced translocation of p52 as well
as of RelB to the nuclei, indicating that CD27 also stimu- by TNF, PMA, or Endoplasmic Reticulum Stress
Studies of the effects of various ligands of the TNF familylates the alternative NF-B pathway in these cells (Fig-
ure 1A). on NF-B activation in lymphocytes have demonstrated
activation of both the canonical and the alternative NF-CD70 also potently induced IB degradation as well
as nuclear translocation of RelB and p52 in cells of the B pathways by CD40L and BLyS/BAFF. On the other
hand, TNF, though capable of effectively triggering theRamos and (to a lesser extent) of the Raji lymphoblastoid
lines (Figure 1C and left panels in Figures 1D and 1E). canonical pathway, appears unable to trigger the alter-
native pathway (Matsushima et al., 2001; Yin et al., 2001;This translocation was associated with an increase in
the total cellular content of p52 (Figure 1F). Both in Dejardin et al., 2002; Yilmaz et al., 2003). It induces only
a slight increase in nuclear p52, much less than thatthe Ramos cells and in HEK293T cells transfected with
CD27, CD70 also induced generation of p52 from p100 induced by ligands such as CD40L (Yilmaz et al., 2003;
Derudder et al., 2003), probably through stimulating themolecules encoded by transfected cDNA, and this pro-
NIK-Mediated Canonical NF-B Pathway Activation
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Figure 1. CD27 Induces Both the Canonical and the Alternative Pathways in Lymphocytes, and Their Induction Is Prevented by Arrest of
NIK Synthesis
Effects of CD70 on the cytoplasmic levels of IB and on the cytoplasmic and nuclear levels of NF-B proteins in (A) resting PBMC, (B) PBMC
stimulated for 48 hr with PHA (1 g/ml) followed by a 12 hr resting period without PHA, (C) Raji cells, and (D) and (E) Ramos cells (normal
and NIK). Effects of CD70 (F) on the total endogenous cellular levels of p100 and p52 in Ramos cells and on the total levels of p100 and
p52 encoded by transiently expressed cDNA for p100 fused at its N terminus to the myc tag (myc-p100) in (G) Ramos cells and in (H) HEK293T
cells that transiently express CD27. The effect of transiently expressed myc-NIK on p100 processing in the HEK293T cells served as a positive
control. The effect of the proteasomal inhibitor MG132 on p52 generation in the myc-p100-transfected cells was assessed in the Ramos cells
by applying it for the last 2 hr of a 4 hr period of stimulation with CD70 and in the HEK293T cells by applying it throughout the 4 hr period of
incubation with CD70. (I) Effect of CD70 on p100 ubiquitination in Ramos cells, assessed in the presence and in the absence of the proteasomal
inhibitor MG132. (NS, nonspecific)
synthesis of p100 (de Wit et al., 1998) and releasing Supplemental Figure S1 at http://www.immunity.com/
cgi/content/full/21/4/477/DC1/) with no visible changep52:p65 dimers held latent in the cytoplasm by IB
(Coope et al., 2002). TNF also induces synthesis of RelB in the cellular levels of IB (see Hatada et al. [2003] for a
similar effect of BLyS/BAFF on primary B lymphocytes).(Bren et al., 2001), part of which accumulates in the
nucleus, apparently through induced nuclear transloca- CD40L and BLyS/BAFF also induced marked increases
in nuclear p52 as well as in RelB (left panels of Figurestion of p100:RelB dimers (Yilmaz et al., 2003).
The responses of the Ramos cells to CD40L, BLyS/ 3A and 3C). TNF induced nuclear translocation of RelB,
but only a slight increase in nuclear p52 (Figure 3E, left).BAFF, and TNF in this study were consistent with those
reports. All three ligands induced activation of the ca- Assessment of coimmunoprecipitation of various NF-
B proteins from nuclear extracts of the Ramos cellsnonical pathway, as reflected in rapid nuclear transloca-
tion of p65 (left panels of Figures 3B, 3D, and 3F). This confirmed that whereas CD70 enhances nuclear accu-
mulation mainly of RelB:p52 (and of RelB:p100), TNFtranslocation was associated with a decrease in IB
(left panels of Figures 3B and 3F) or, in the case of BLyS/ induces increased nuclear levels of RelB:p100 without
increasing RelB:p52 (Figure 3G).BAFF, phosphorylation of IB (Figure 3D, left) as well
as increased DNA binding of the p65:p50 dimer (see On further examining the impact of the arrest of NIK
Immunity
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Figure 2. siRNA-Mediated Ablation of NIK Synthesis in Ramos Cells and Its Restoration by Transfection of Wild-Type or Mutant NIK cDNA
(A) Suppression of NIK synthesis by expression of NIK siRNA. Top: suppression of the synthesis of transiently expressed myc-tagged NIK in
HEK293T cells by cotransfection of pSUPER-NIK at ratios of 1:1, 1:2, 1:3, and 1:5. Middle: analysis of NIK (and, for comparison, of IKK1) in
Ramos cells constitutively expressing lentiviral-pSUPER-NIK (NIK cells) in comparison to Ramos cells transduced with lentiviral-GFP as
control. Bottom: reconstitution of NIK expression in the NIK Ramos cells by constitutive expression of myc-tagged NIK.
(B) CD70-induced PKC activation in normal (black bars) and NIK (white bars) Ramos cells. Bars represent the means of triplicate tests. CD27
levels in normal and NIK Ramos cells are shown in the inset.
(C and D) CD70-induced degradation of IB and nuclear accumulation of p52 in (C) NIK cells reconstituted with wild-type NIK and (D)
normal Ramos cells (control), NIK cells, and NIK cells reconstituted with KD-NIK and with aly-NIK. Western blot analysis of the expression
of the myc-tagged NIK mutants is shown at the bottom of (D). WB, Western blot; IP, immunoprecipitation.
expression on the response of the Ramos cells to the NIK depletion also had no effect on IB degradation
in response to thapsigargin, an inhibitor of the sarco-three ligands, we found that as with the effects of CD70,
all effects of CD40L and BLyS/BAFF on NF-B activa- endoplasmic reticulum Ca2-adenosine triphosphatase
that triggers activation of NF-B through induction oftion—those ascribed to the canonical pathway as well
as those related to the alternative pathway—were ar- endoplasmic reticulum stress (Pahl and Baeuerle, 1996),
or to 4-phorbol-12-myristate-13-acetate, an agent acti-rested in the NIK cells (right panels of Figures 3A–3D).
Similarly, transfection of cells of the Raji lymphoblastoid vating NF-B through stimulation of PKC (Sen and Balti-
more, 1986) (Figure 3I).line with NIK siRNA resulted in a marked decrease in
activation of both the canonical and the alternative NF-
B pathways by CD40L (Figure 3H). In contrast, the NIK-Dependent Activation of the Canonical Pathway
Can Be Blocked by Introduction of an Anti-NIKinduction of IB degradation by TNF and the resulting
nuclear translocation of p65, as well as the induction of Antibody into Cells
Besides the loss of responsiveness to the effects ofnuclear translocation of p100 and RelB by TNF, occurred
in the NIK-deficient cells just as effectively as in the CD70, CD40, and BLyS/BAFF on NF-B, the NIK-defi-
cient Ramos cells also displayed some constitutive al-cells expressing NIK (right panels of Figures 3E and 3F).
NIK-Mediated Canonical NF-B Pathway Activation
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Figure 3. Ablation of NIK Synthesis in Lymphoblastoid Cells Compromises Activation of Both the Canonical and the Alternative NF-B Pathways
by CD40L and BLyS/BAFF but Does Not Affect Activation of the Canonical Pathway by TNF, Thapsigargin, or PMA
(AF; I) Kinetic analysis of the responses of normal and NIK Ramos cells to the indicated ligands. Thapsigargin was applied at 5 M as
described (Leonardi et al., 2002) and PMA at 100 ng/ml. For detection of phosphorylated IB, cells were pretreated for 2 hr with the
proteasomal inhibitor MG132.
(G) An immunoprecipitation analysis of the NF-B complexes that occur in the nuclei of Ramos cells 15 min and 4 hr after application of TNF
or CD70 to the cells.
(H) The response of Raji cells to CD40 ligand and its modulation by siRNA-mediated suppression of NIK synthesis.
(J) A comparison of basal levels of the various NF-B proteins in control and NIK Ramos cells.
terations of their basal NF-B protein levels (Figure 3J). peptide corresponding to the phosphorylated NIK acti-
vation loop (-pNIK) effectively blocked the in vitro ki-Expression of those NF-B proteins whose levels were
found to decrease is known to depend in part on NF- nase function of NIK (Figure 4A). We therefore attempted
to introduce these antibodies into the Ramos cells as aB activation. This decrease is reminiscent of that ob-
served in lymphocytes of aly mice (Yamada et al., 2000). means of blocking NIK function. As shown in Figure 4B,
treatment of the Ramos cells with a protein transfectionIt probably reflects arrest of the effects of some auto-
crine mediators that continuously cause mild activation kit allowed effective, though transient, introduction of
immunoglobulins into the cells. Introduction of theof NF-B in a NIK-dependent manner in the Ramos cells.
To exclude the possibility that the differences in ligand -pNIK antibodies into the Ramos cells had no effect
on the induction of IB degradation by TNF. However,effects observed between the NIK-deficient and the nor-
mal cells are secondary to such constitutive alterations the antibodies effectively blocked the induction of IB
degradation by CD70 or CD40L (Figure 4C). On examin-occurring in the cells as a consequence of prolonged
NIK deficiency, we sought a way to instantaneously ab- ing cells of several other lymphoblastoid lines, we found
those of the BJAB line to be just as amenable to transfec-late NIK function in cells. NIK activation requires phos-
phorylation of its activation loop (Lin et al., 1998). A tion with the antibodies as the Ramos cells. CD40L (but
not CD70) induced IB degradation in these cells, andmonoclonal antibody that we raised against a phospho-
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as well as p65 nuclear translocation in these cells in
response to either TNF or CD70 but had no effect on the
CD70-induced nuclear accumulation of p52 (Figure 5A).
The two NF-B activation pathways also differ with
regard to the IKK species that mediate them. IB phos-
phorylation is mediated by IKK2 and was reported to
occur also in cells devoid of IKK1 (Ghosh and Karin,
2002). In contrast, the phosphorylation that targets p100
for processing depends on IKK1. Consistently, siRNA-
mediated suppression of the synthesis of this kinase
in Ramos cells decreased the CD70-induced nuclear
accumulation of p52. Surprisingly, IKK1 depletion also
compromised the induction of IB degradation and
of p65 nuclear translocation by CD70, suggesting that
some unique, IKK1-dependent mechanism participates
in activation of the canonical pathway by CD70 (Fig-
ure 5B).
Both TNF and CD70 were found to enhance the in vitro
kinase function of the IKK signalosome as manifested
by the effectiveness of the self-phosphorylation of the
IKKs and phosphorylation of their associated NEMO
(Figure 5C) as well as by the effectiveness of the in vitro
IKK-mediated phosphorylation of GST-IB (Figure 5D).
However, whereas activation of the signalosome by TNF
was not affected by NIK deficiency, the effect of CD70
Figure 4. Introduction of Antibodies against the Phosphorylated Ac- on the signalosome was aborted in NIK-deficient cells
tivation-Loop of NIK (p-NIK) into Ramos and BJAB Cells Blocks (Figures 5C and 5D).
the Induction of IB Degradation by CD70 and CD40L, but Not
These findings suggest that both TNF and CD70 medi-by TNF
ate phosphorylation of IB by activation of the IKK
(A) In vitro inhibitory effect of p-NIK on NIK kinase function. Self-
signalosome complex, but that the activation in re-phosphorylation of myc-NIK immunoprecipitated from transiently
sponse to the two ligands occurs via different mecha-transfected HEK293T cells was determined in the presence of in-
creasing amounts of p-NIK (0.5 g, 1.0 g, and 2 g/25 l kinase nisms, with only the CD70 effect being dependent on
reaction volume) or with control IgG (2 g). Autoradiogram of the NIK and on IKK1 function.
phosphorylated protein is compared to Western blot analysis of NIK
levels in the same samples.
NF-B Activation by CD27 Is Associated with Receptor(B) Introduction of antibodies into Ramos cells with a protein-trans-
Recruitment of the Signalosome and of Just IKK1fection reagent. Uptake of FITC-tagged immunoglobulin by the
Ramos cells was assessed by fluorescence microscopy at the indi- In a Manner Dependent on NIK Kinase Function.
cated times after transfection. It Is Also Associated with Recruitment of NIK
(C) Assessment of the effect of introduction of p-NIK antibody (or, Itself to the Receptor Independently
for comparison, of mouse IgG or of -NIK81 that had no effect on of Its Kinase Function
NIK kinase activity in vitro) on the induction of IB degradation by
The earliest known event in activation of the signalo-CD70, CD40L, and TNF in Ramos cells and (D) by CD40L in BJAB
some by TNF is its recruitment to the p55 TNF receptor,cells. The ligands were applied 4 hr after transfection of the antibody
(10 g/ml of transfection volume) was started. Results are represen- a process facilitated by recruitment of the adaptor pro-
tative of three experiments, each performed in duplicate. teins RIP and TRAF2 to that receptor. CD70 does not
induce recruitment of RIP to CD27. However, as shown
in Figure 6A, it does induce recruitment of TRAF2. Inter-
this induction was significantly reduced when the estingly, the TRAF2 molecules recruited to CD27 dis-
-pNIK antibodies were introduced (Figure 4D). These played extensive electrophoretic pattern modification,
findings further confirm that although NIK does not par- probably corresponding to ubiquitination. CD70 also in-
ticipate in activation of the canonical pathway by TNF, duced recruitment of the signalosome. Recruitment of
its function in lymphocytes is crucial for activation of the signalosome to the TNF receptor was prolonged,
the canonical pathway by some other ligands. whereas association of the three components of the
signalosome with CD27 could be observed only for a
few minutes. At later time points, the amounts of IKK2NIK Is Required for Activation of the IKK Kinase
Complex by CD70 but Not for Its Activation by TNF and NEMO in the CD27 complex sharply decreased.
Surprisingly, however, the amounts of IKK1 associatedThe critical event in the canonical pathway is stimulation
of the IKK signalosome, a complex formed between with the receptor remained high for a long time (Figure
6A, left). Similar selective maintenance of IKK1 in associ-the IB-kinases and NEMO. On the other hand, since
activation of the alternative pathway is independent of ation with CD27 after CD70 treatment was also observed
in PBMC (Figure 6B).NEMO, it is believed to be mediated through activation
of kinase complex(es) distinct from the signalosome. Both TNF and CD70 also induced recruitment of all
three components of the canonical NF-B complexConsistently, siRNA-mediated depletion of NEMO from
the Ramos cells greatly decreased IB degradation (IB, p65, and p50). Although p100 processing is in-
NIK-Mediated Canonical NF-B Pathway Activation
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Figure 5. CD70 Induces Stimulation of the IKK Signalosome and NF-B-Activation in a NIK- and IKK1-Dependent Manner
(A and B) Effects of siRNA-mediated ablation of synthesis of (A) NEMO and (B) IKK1 on the responses of Ramos cells to CD70 and TNF.
(C) Self-phosphorylation of the IKKs and phosphorylation of NEMO in an in vitro kinase test of the IKK signalosome 15 min after application
of CD70 or TNF to normal and to NIK Ramos cells.
(D) In vitro IB phosphorylation activity of the IKK signalosome in Ramos cells, isolated both in (C) and in (D) by immunoprecipitation with
antibodies to IKK1, compared to cellular IB levels at various times after application of CD70 or TNF to normal and to NIK Ramos cells.
duced by CD70 and not by TNF, receptor recruitment to CD27 depends on the NIK kinase function, recruit-
ment of NIK itself to the receptor seems to occur inde-of p100 was induced by TNF, but not by CD70 (Figure
6A, right). This recruitment was previously suggested to pendently of its enzymatic activity.
occur through binding of the death domain in p100 to
that in the p55 TNF receptor-associated adaptor protein Discussion
TRADD and appears to serve not to activate NF-B
but to amplify death induction by this receptor through The restricted pattern of biological functions in which
NIK participates appears to be at variance with whatcaspase-8 activation (Wang et al., 2002).
In NIK cells, recruitment to the p55 TNF receptor might be anticipated from the wide-ranging impact that
this enzyme can have on NF-B activation. NIK can bindoccurred just as effectively as in the wild-type cells (Fig-
ure 6C, right). In contrast, recruitment of the signalo- IKK1 and activate it (Regnier et al., 1997; Ling et al.,
1998). It can also bind p100 and phosphorylate it (Xiaosome components to CD27 was completely abolished
(Figures 6C and 6D, left panels). Introduction of wild- et al., 2001), and, by activating IKK1, it facilitates the
phosphorylation of p100 by the latter kinase (Senftlebentype NIK, but not of “kinase-dead” NIK, to the NIK cells
reinstated the recruitment in response to CD70 (Figure et al., 2001). Activation of IKK1 by NIK can also lead to
phosphorylation and activation of IKK2 by IKK1 and,6D, middle and right).
CD70, but not TNF, also induced recruitment of NIK consequently, to IKK2-mediated phosphorylation of IB
(O’Mahony et al., 2000). NIK thus seems to be capableto its receptor. This recruitment could be observed both
in cells expressing the wild-type enzyme and in those of activating both the alternative and the canonical NF-
B activation pathways. The present study shows thatthat expressed its kinase-dead mutant (Figure 6D). Thus,
while the recruitment of the signalosome components NIK indeed participates in the activation of both path-
Immunity
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Figure 6. CD70 Induces Recruitment of the IKK Signalosome Followed by Selective Recruitment of IKK1 to CD27 in a Way that Depends on
NIK Kinase Function as Well as Recruitment of NIK Independently of Its Kinase Function
(A) Kinetic analysis of recruitment of TRAF2 and RIP, the components of the IKK signalosome (IKK1, IKK2, and NEMO), the components of
the canonical NF-B complex (IB, p65, and p50), and p100 to CD27 and the p55 TNF receptor complexes in Ramos cells at various time
points after CD70 or TNF application, compared to composition of the cytoplasmic IKK signalosome (isolated, prior to stimulation, by the use
of an antibody to NEMO; right) and to the cellular levels of IB (bottom).
(B and C) In vitro IB phosphorylation activity and the presence of IKK signalosome components in receptor complexes and cytoplasmic
signalosomes. (B) CD27 complexes and signalosome preparations isolated from resting PBMC before stimulation and after stimulation with
CD70 for 20 min. (C) Receptor complexes associated with CD27 (left) and the p55 TNF receptor (right) isolated from control and NIK Ramos
cells before stimulation and after stimulation with CD70 or TNF for 20 min.
(D) Comparison of the kinetics of recruitment of NIK and IKK1 to CD27 and to the p55 TNF receptor complexes at various times after application
of CD70 or TNF to NIK Ramos cells and to NIK cells replenished with wild-type or enzymatically inactive NIK mutant (KD-NIK).
NIK-Mediated Canonical NF-B Pathway Activation
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Figure 7. Speculative Model of the Mechanisms Initiating NF-B Activation by TNF and CD70
The figure presents an outline of the molecular events leading from activation of the p55 TNF receptor by TNF (left) and of the CD27 receptor
by CD70 (right) to NF-B activation. TNF induces NIK-independent recruitment of all three core components of the signalosome to its receptor
in a way that depends on interaction of these components with TRAFs and RIP. This recruitment initiates the canonical pathway only. CD70
induces recruitment and massive ubiquitination of TRAF2, but not of RIP. It also induces the recruitment of NIK and, in a way that depends
on the kinase function of NIK, induces also the recruitment first of the whole signalosome and then of only IKK1 to CD27. Recruitment of the
whole signalosome to this receptor and the consequent activation of IKK1 in it by NIK might be the mechanism for initiation by this receptor
of the canonical pathway, and the subsequent recruitment of IKK1 might be the mechanism for initiation by this receptor of the alternative
pathway. Broken lines pointing at p100 or RelB represent their induction upon activation of the canonical pathway by TNF and CD70 and the
consequent translocation of the p100:RelB complex to the nucleus.
ways, but that this participation is inducer specific. It dependent activation by CD70 might provide a clue as
to how the participation of NIK in activation of the canon-was detectable only in response to ligands capable of
stimulating both the canonical and the alternative NF- ical pathway is restricted to the effect of specific in-
ducers. Activation of the canonical pathway by CD70,B activation pathways and not in response to an in-
ducer such as TNF, which (at least in the cells studied like its activation by TNF, is associated with recruitment
of the signalosome components IKK1, IKK2, and NEMOhere) can stimulate only the canonical pathway. Some
of the receptors that signal for NF-B activation can do to the receptor complex. Unlike TNF, however, CD70
also induces recruitment of NIK to its receptor. More-so by more than one mechanism, with each mechanism
operating in a different region of the receptor’s intracel- over, NIK deficiency, while not affecting recruitment of
the signalosome to the TNF receptor, prevented its re-lular domain and leading to activation of a different set
of NF-B dimers (e.g., Coope et al. [2002] and Saito et cruitment to CD27.
Expression of kinase-dead NIK or the NIK aly mutantal. [2003]). NIK might thus turn out to function in a way
that is even more restricted by participating in one of failed to restore the response to CD70. This failure is
probably due in part to the inability of these mutantsthe mechanisms of signaling by a receptor, and not in
the others, and thus contributing to the function of this to phosphorylate IKK1. The finding that IKK1 depletion
compromised the induction not only of the alternativereceptor only in particular cell types and differentiation
states. Some of the data obtained while assessing the pathway but also of the canonical pathway by CD27 is
indeed consistent with the suggestion that in the caseimpact of the NIK aly mutation or of overexpression of
its kinase-dead mutant on NF-B activation are indeed of this receptor, NIK-mediated IKK1 phosphorylation is
crucial for activation of both pathways. Our findingsconsistent with the notion that this kinase participates
in activation of the canonical pathway in a way that is indicate, however, that the kinase function of NIK con-
tributes not only to phosphorylation of IKK1 but alsospecific both to certain cell types and to a particular
receptor (Garceau et al., 2000; Smith et al., 2001). to recruitment of the signalosome components to the
CD27 complex.Our comparison of the initiating events in the NIK-
independent activation of NF-B by TNF and in the NIK- CD27 associates with members of the TRAF adaptor
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relevant expression constructs (see below). TNF, a gift from Dr. G.family. The ability of NIK to bind to these adaptor pro-
Adolf, Boehringer Institute, Vienna, Austria, was applied to cells atteins might assist its recruitment to CD27. However,
a concentration of 100 ng/ml. MG132 was purchased from Calbio-TRAFs also associate with the TNF receptor, to which
chem, and thapsigargin, 4-phorbol-12-myristate-13-acetate, and
NIK is not recruited. In fact TRAFs associate with all phytohemagglutinin (PHA) from Sigma. [32P]ATP and Ficoll-Paque
members of the TNF/NGF family, and yet only some were from Amersham Biosciences, G418 from Life Technologies,
of these receptors are known to involve NIK in NF-B and the MACSelect Kk.II transfected cell selection kit was from Mil-
tenyi Biotec.activation. Thus, there must be other determinants, in
addition to the association of TRAFs with a receptor, that
Antibodiesdictate NIK recruitment to this receptor and activation of
Anti-p52 antibody was purchased from Upstate Biotechnologies; anti-NF-B by the receptor in a NIK-dependent manner.
bodies against p65, p52, p50, RelB, c-Rel, CD27, TRAF2, Lamin A/C,
Recruitment of the signalosome along with NIK to Oct-1, NEMO, and IKK1 (M280 and H744) from Santa Cruz Biotechnol-
CD27 is followed shortly by a sharp decrease in both ogy; anti-RIP, anti-IKK2, and anti-NEMO antibodies from BD-Phar-
IKK2 and NEMO in the receptor complex. Both IKK1 mingen; anti-FLAG, anti-FLAG M2-beads, and anti- actin from Sigma;
anti-ubiquitin from Covance, anti-IB from Transduction Labora-and NIK, however, remain associated with the receptor
tories; and anti-phospho-IB from Cell Signaling Technology. Afor a long time. The latter form of the CD27 complex
monoclonal antibody against the phosphorylated NIK activation loopprobably serves to initiate the alternative pathway pre-
(-pNIK) was raised by immunizing mice with a KLH-coupled peptideviously shown to depend on the function of IKK1 and
corresponding to the NIK activation loop in which Thr559 was phos-
NIK but not of IKK2 or NEMO (see the hypothetical model phorylated. The anti-NIK monoclonal antibody NIK-81 was raised
in Figure 7). by immunizing mice with a KLH-coupled peptide corresponding to
Like the recruitment of the whole signalosome to a sequence within the NIK kinase domain (RLGRGSFGEVHRMEDK;
amino acids 405–420). Both anti-NIK and anti-myc (clone-9E10)CD27, the subsequent preferential association of IKK1
monoclonal antibodies were purified from mouse ascitic fluids onwith the receptor cannot be observed in cells devoid of
affinity columns to which their corresponding peptides wereNIK or in cells expressing nonfunctional NIK mutants. It
coupled.is tempting to speculate that these two stages in the
recruitment are mechanistically linked, thereby ensuring
Cells
that initiation of the NIK-dependent alternative activa- PBMC were isolated from buffy coat samples by Ficoll-Paque gradi-
tion pathway is coupled to that of the canonical pathway. ent centrifugation at 450  g. The PBMC, as well as cells of the
Indeed, whereas there are many stimuli that activate the human B lymphoblastoid lines of Burkitt lymphoma origin, Ramos,
Raji, and BJAB, were cultured in RPMI medium, and HEK293T cellscanonical pathway alone, all agents found to date to
in Dulbecco’s modified Eagle’s medium supplemented with 10%activate the alternative pathway are also known to acti-
fetal calf serum, 100 U/ml penicillin, and 100 g/ml streptomycin.vate the canonical one. This dual ability has clear physio-
logical significance. The NF-B dimers generated by the
Expression Vectorstwo pathways recognize different DNA sequence motifs
The cDNAs for the extracellular domains of mCD70, hCD40L, and
and, thus, by affecting different promoters, can control hBLyS/BAFF were PCR-amplified from ESTs and cloned in fusion
the expression of different genes (Perkins et al., 1992; with a leader sequence, a modified leucine zipper, and FLAG tag
Lin et al., 1995; Dejardin et al., 2002; Hoffmann et al., (Fanslow et al., 1994) into pcDNA3 (Invitrogen). pCS3MTNIK and
pCS3MT-NIK KK429–430AA, expression vectors for wild-type and2003). However, activation of both pathways by the
kinase-dead NIK fused N-terminally to the myc tag, were obtainedsame inducers allows for functional interactions be-
from Dr. Michael Kracht, Germany. N-terminally myc-tagged p100tween the genes regulated by the two pathways. More-
(myc-p100) was constructed by PCR with pCMVSPORT6-p100 (In-over, it allows the two signaling pathways to affect each
vitrogen) as the template and then cloned into pcDNA3. The expres-
other’s activation. Thus, by triggering the synthesis of sion vector encoding human CD27 (pcDNAGS-hCD27) was pur-
p100 as well as of RelB (de Wit et al., 1998; Bren et al., chased from Invitrogen. pEGFP was purchased from Clontech.
2001), which together form the precursor dimer affected Human NIK with a mutation (G860R) corresponding to that of the
mouse aly mutation (G855R) (Shinkura et al., 1999) was generatedby the alternative pathway, the canonical pathway po-
with a site-directed mutagenesis kit (Stratagene). (The sequencestentiates the alternative pathway. Conversely, since—in
of the oligonucleotides used for site-directed mutagenesis, PCR,addition to binding to RelB—p100 also associates with
and suppression of protein synthesis by RNA interference are listedthe dimers controlled by the canonical pathway and thus
in the Supplemental Data.)
blocks their function, its processing by the alternative
pathway helps to perpetuate the activation of the canon- Plasmid Transfections, Immunoblotting,
ical pathway. and Immunoprecipitations
To allow for coordination of the activation mecha- For detection of endogenous NIK, Ramos cells (24  108; 1  108
cells/ml) were lysed and NIK was immunoprecipitated from the ly-nisms for the two functionally distinct yet interacting
sate with affinity-purified mouse anti-NIK antiserum coupled to pro-sets of NF-B dimers by the same inducer, they need
tein G-Sepharose beads. The precipitated protein was detected byto be controlled by both common and distinct regulatory
Western blotting with the NIK-81 antibody and the SuperSignal Westelements. Previous studies have disclosed several com-
Femto Chemiluminescent Detection Kit (Pierce).
ponents unique to the alternative or to the canonical For immunoprecipitation of the CD27-receptor complexes, ly-
pathway. Our study shows that NIK can serve as a com- sates of CD70-treated cells, prepared as described for the kinase
mon proximal signaling molecule in situations where tests below, were incubated for 4 hr at 4	C with 25 l of 50% M2-
FLAG agarose beads per ml of lysate. The TNF-receptor complexboth mechanisms of NF-B activation are triggered.
was precipitated as described (Zhang et al., 2000). The signalosome
from cell lysates was immunoprecipitated through IKK1 or NEMOExperimental Procedures
as described (Dejardin et al., 2002).
For immunoprecipitation of the NF-B proteins with anti-RelBReagents
antibody, nuclear extracts from 1020  106 cells were diluted tomCD70, hCD40L, and hBLyS/BAFF were produced by large-scale
transfection of human embryonic kidney (HEK) 293T cells with the achieve the following composition: 0.5% NP-40, 10 mM HEPES (pH
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7.9), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol For exploration of the effectiveness of the pSUPER-NIK, HEK293T
cells were transfected by the calcium phosphate precipitation(DTT), 1 mM PMSF, and 1 complete protease inhibitor cocktail.
The immunoprecipitated proteins were resolved on 4%12% Bis- method (Sambrook et al., 1989) with this plasmid together with
pCS3MT-NIK. To express the pSUPER-NIK constitutively in theTris NuPAGE gels (Invitrogen), transferred to a nitrocellulose mem-
brane, and analyzed with the enhanced chemiluminescence (ECL) Ramos cells, we used a lentiviral vector as described (Lois et al.,
2002). The cassette of H1 promoter  NIK RNAi was transferredWestern blotting detection system (Amersham).
For ligand activation of lymphoid cell lines and PBMC, typically from the pSUPER vector to the GFP-expressing FUGW lentiviral
vector. Transduced cells were sorted by FACS for GFP expression1  106 cells were stimulated for the indicated time periods with
the relevant ligands, and nuclear and cytoplasmic extracts were (FACS Vantage, Becton-Dickinson). The sorted cells continued to
manifest expression of GFP and deficiency of NIK for months.prepared as described (Schreiber et al., 1989) and analyzed by West-
ern blotting. Raji cells were depleted of NIK by nucleofection (solution V, pro-
gram S18) with a mixture of 4 g of NIK siRNAs (3 g of siRNAmyc-p100 was transiently expressed in Ramos cells by nucleofec-
tion with the nucleofector kit T and program G10 (Amaxa biosys- #1511 and 1 g of #NC3; Ambion) and 1 g of the pMACS Kk.II
plasmid (for selection of the transfected cells). Cells nucleofectedtems). Cells were stimulated with CD70 16 hr after nucleofection for
the indicated time periods, and this was followed by Western analy- with lamin A siRNA served as a control. Cells were selected by
magnetic sorting 36 hr after transfection, according to the manufac-sis of the whole-cell lysates.
For assessment of CD27-induced processing of ectopically ex- turer’s instructions (Miltenyi Biotec). Sorted cells were allowed to
grow for a further 36 hr and were then stimulated with CD40L forpressed myc-p100 in HEK293T cells, the cells were cotransfected
with myc-p100 and human CD27 expression vectors (or, as a posi- the indicated times.
Ramos cells were depleted of NEMO by nucleofection (solutiontive control, with myc-NIK vector). Twenty-four hours after CD27
transfection CD70 was applied for 4 hr with or without MG132 (25 V, program G16) with a mixture of the relevant pSuper construct
(1.5 g) and NEMO-specific Smartpool siRNA (3.5 g; Dharmacon).M in all experiments), and this was followed by lysis and West-
ern blotting. They were depleted of IKK1 by nucleofection (solution V, program
G10) with a mixture of three pSUPER-RNAi constructs for IKK1Ubiquitination of p100 was assessed as described (Mordmuller et
al., 2003). The p100 was immunoprecipitated from CD70-stimulated (1 g each) and a synthetic siRNA (2 g). As controls, Ramos cells
were nucleofected with pSUPER containing a scrambled siRNA se-cells with a mixture of two anti-p100 antibodies (C5, Santa Cruz and
anti-NFB2, Upstate). MG132 was applied for the last hour of the 4 quence plus lamin A siRNA. Stimulation with CD70 or TNF was done
30 hr after nucleofection in NEMO-depleted cells and 72 hr afterhr stimulation. For Western analysis of the whole-cell lysate, cells
were boiled in 1 LDS sample buffer (Invitrogen). nucleofection in IKK1-depleted cells.
For reintroduction of NIK and its mutants into the NIK cells, the
cells were nucleotransfected with the NIK-expressing vector with Protein Kinase C Assay
PKC activity in control and NIK-deficient Ramos cells after CD70the Nucleofector Kit V, according to the manufacturer’s instructions
(Amaxa Biosystems). Briefly, 2  106 NIK cells were nucleofected stimulation was measured by the Signatect Protein Kinase C Assay
System (Promega). The enzymatic activity of PKC was determinedwith 4 g of NIK plasmid and 1 g of pEGFP in solution V in the
Nucleofector device with program S18 or G10. Cells stably express- by subtracting the values obtained when assaying in the absence
of phospholipids from those obtained in their presence.ing the transfected proteins were selected for growth in G418
(1 mg/ml).
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